| Insulin Detemir in Obesity Management (NCT01239550) | Vanderbilt University | 2011-04-01 |
| Implementation of an Integrated Primary Care Network for Prevention and Management of Cardiometabolic Risks (NCT01326130) | Public Health Department, Montreal | 2011-04-01 |
| A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in India (NCT01351922) | Novo Nordisk A/S | 2011-04-01 |
| Study of Medical Assistant Health Coaching in Primary Care for Patients With Chronic Conditions (NCT01220336) | University of California, San Francisco | 2011-04-01 |
| Effect of Pharmacological Anti-lipolysis on FFA and VLDL-TG Metabolism Before and During Exercise (NCT01260376) | University of Aarhus | 2011-04-01 |
| Assessment of Response Rates and Yields for Two Tools for Early Detection of Non-diabetic Hyperglycaemia and Diabetes (NCT00950313) | University of Leicester | 2011-04-01 |
| Computerized Intervention of Parental Involvement in Diabetes Care of Their Child (NCT01515930) | Wayne State University | 2011-04-01 |
| Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus (NCT01326026) | Novo Nordisk A/S | 2011-03-01 |
| Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations (NCT01387659) | The University of Texas Medical Branch, Galveston | 2011-03-01 |
| Health and Faith (Salud y Fe): Community-Based Diabetes Pilot Intervention (NCT01288300) | University of Chicago | 2011-03-01 |
| Walking Exercise and Nutrition to Reduce Diabetes Risk for You (WENDY) (NCT01247753) | University of Michigan | 2011-03-01 |
| Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes (NCT01324505) | Novo Nordisk A/S | 2011-03-01 |
| Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone (NCT01215435) | Novo Nordisk A/S | 2011-03-01 |
| Effect of Phacoemulsification on Ocular Blood Flow in Human (NCT01305005) | yin ying zhao | 2011-03-01 |
| Medium Term Health Coaching and Life-long Monitoring in Cardiovascular Disease in Norrbotten (NCT01478672) | Luleå Tekniska Universitet | 2011-03-01 |
| DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists (NCT01575301) | University of Dundee | 2011-03-01 |
| Pharmacy Home Adherence Reporting and Monitoring Outcomes Study (NCT02306122) | Brown University | 2011-03-01 |
| Guided Self-determination - Promoting Self-management in Type 1 Diabetes (NCT01317459) | Haukeland University Hospital | 2011-03-01 |
| Blood Pressure Telemonitoring and Goal Blood Pressure in Diabetes (NCT01300338) | Mayo Clinic | 2011-03-01 |
| Diabetes in the Elderly: Prospective Study (NCT01131052) | Guillermo Umpierrez | 2011-03-01 |
| Insulin Pump Therapy and Continuous Glucose Monitoring in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients (NCT01324557) | Guangdong Provincial People's Hospital | 2011-03-01 |
| PictureRx: An Intervention to Reduce Latino Health Disparities (NCT01618409) | PictureRx, LLC | 2011-03-01 |
| Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects (NCT01319240) | Novo Nordisk A/S | 2011-03-01 |
| Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes (NCT01288326) | Novo Nordisk A/S | 2011-02-01 |
| Social Work Intervention Focused on Transitions (NCT02232126) | University of Southern California | 2011-02-01 |
| Way to Health, Healthy Measures (NCT01282957) | University of Pennsylvania | 2011-02-01 |
| Personalized Medicine for Diabetes Prediction and Prevention of Complications (NCT01268813) | Rambam Health Care Campus | 2011-02-01 |
| A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1 (NCT01296438) | Novo Nordisk A/S | 2011-02-01 |
| Genetic Association of Diabetic Retinopathy-1 (NCT01298245) | Taipei Veterans General Hospital, Taiwan | 2011-02-01 |
| Integration of Chronic Disease Rehabilitation Services Into Primary Care (NCT01319656) | Martin Fortin | 2011-02-01 |
| An Observational Post-Marketing Safety Registry of Sativex® (NCT02073474) | Jazz Pharmaceuticals | 2011-02-01 |
| Investigation of the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 in Healthy Chinese Subjects (NCT01242826) | Novo Nordisk A/S | 2011-02-01 |
| The Hanapū Study: Incentivized Partnerships to Reduce Diabetes Disparities (NCT02861144) | University of Hawaii | 2011-02-01 |
| Promoting Physical Activity in Patients With Type 2 Diabetes (DIAfit) (NCT01289587) | University of Lausanne Hospitals | 2011-02-01 |
| Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes (NCT01272193) | Novo Nordisk A/S | 2011-01-01 |
| Metformin to Reduce Heart Failure After Myocardial Infarction (NCT01217307) | University Medical Center Groningen | 2011-01-01 |
| Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic Activity (NCT01888315) | University Hospital, Saarland | 2011-01-01 |
| Maintaining Resistance Training in Older Prediabetic Adults (NCT01112709) | Virginia Polytechnic Institute and State University | 2011-01-01 |
| Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes (NCT01269606) | Novo Nordisk A/S | 2011-01-01 |
| Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects (NCT01272973) | Novo Nordisk A/S | 2011-01-01 |
| A Placebo-Controlled, Randomized, Safety and Efficacy Study to Evaluate the Change in Hemoglobin A1c Levels in Type 2 Diabetic Subjects While Taking Nutralin (NCT01275027) | Avera McKennan Hospital & University Health Center | 2011-01-01 |
| Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756 (NCT01278160) | Novo Nordisk A/S | 2011-01-01 |
| Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics (NCT02922179) | Biologics & Biosimilars Collective Intelligence Consortium | 2011-01-01 |
| Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics (NCT02042664) | Assistance Publique Hopitaux De Marseille | 2011-01-01 |
| HOPE Pilot for Veterans With Complex Diabetes (NCT01274715) | Michael E. DeBakey VA Medical Center | 2011-01-01 |
| CARDIA Brain MRI Substudy (NCT01273311) | National Institute on Aging (NIA) | 2010-12-22 |
| Performance of an Investigational Blood Glucose Monitoring System in a Clinical Trial (NCT01328717) | Ascensia Diabetes Care | 2010-12-01 |
| Metabolic Characteristics of Lean Diabetes in Rural and Semi-urban India and in the United States (NCT02987335) | Albert Einstein College of Medicine | 2010-12-01 |
| Using Pharmacogenetics to Improve Treatment in Early-onset Diabetes (NCT01238380) | University of Exeter | 2010-12-01 |
| Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients (NCT01257776) | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 2010-12-01 |
| Cystic Fibrosis - Insulin Deficiency, Early Action (NCT01100892) | Sydney Children's Hospitals Network | 2010-12-01 |
| Performance of an Investigational Blood Glucose Monitoring System in a Clinical Setting (NCT01268267) | Ascensia Diabetes Care | 2010-12-01 |
| Thyroid Function and Diabetes Complications (NCT03001336) | Nanjing First Hospital, Nanjing Medical University | 2010-12-01 |
| Real-world Aliskiren Use in Diabetic Patients (NCT01393860) | Novartis | 2010-12-01 |
| Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes (NCT01134458) | Duke University | 2010-12-01 |
| Performance of an Investigational Blood Glucose Monitoring System in a Clinical Setting (NCT01268488) | Ascensia Diabetes Care | 2010-12-01 |
| Blood Glucose Monitoring System Clinical Study (NCT01327209) | Intuity Medical, Inc | 2010-12-01 |
| A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India (NCT01212133) | Novo Nordisk A/S | 2010-11-01 |
| Carpal Tunnel Release in Diabetic Patients (NCT01201109) | Skane University Hospital | 2010-11-01 |
| Feasibility Study to Assess the Safety and Functionality of the GluSense Continuous Glucose Monitor in Diabetic Patients (NCT01198678) | GluSense Ltd | 2010-11-01 |
| Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part I) (NCT01171703) | Peking Union Medical College Hospital | 2010-11-01 |
| Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B) (NCT01240980) | Bristol-Myers Squibb | 2010-11-01 |
| Cinnamon Bark, Water-Soluble Cinnamon Extract, and Metformin for Treatment of Type 2 DM. (NCT01302743) | Mike O'Callaghan Military Hospital | 2010-11-01 |
| Performance of a New Glucose Meter System (NCT01264016) | Ascensia Diabetes Care | 2010-11-01 |
| Changing Diabetes® World Tour (NCT01437072) | Novo Nordisk A/S | 2010-11-01 |
| Evaluation of the Effects of Heating or Massaging or Vibrating at the Vicinity of the Insulin Delivery Site (NCT00767741) | Insuline Medical Ltd. | 2010-11-01 |
| Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic Patients (NCT01241695) | Fresenius Kabi | 2010-11-01 |
| Effect of Whole Grain Diet on Insulin Sensitivity, Advanced Glycation End Products and Inflammatory Markers in Pre-diabetes (NCT01248286) | Icahn School of Medicine at Mount Sinai | 2010-11-01 |
| Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes (NCT01232491) | Novo Nordisk A/S | 2010-10-29 |
| Multicenter Worksite Nutrition Study (NCT01224548) | Physicians Committee for Responsible Medicine | 2010-10-01 |
| AST Clinical Investigation (NCT01268345) | Andon Medical Co.,Ltd | 2010-10-01 |
| Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases (NCT01546181) | Institut National de la Santé Et de la Recherche Médicale, France | 2010-10-01 |
| Study of a Holistic Health Program for United Methodist Clergy (NCT01564719) | Duke Clergy Health Initiative | 2010-10-01 |
| Enhanced Spanish Drug Label Study to Promote Patient Understanding and Use (NCT01200849) | Northwestern University | 2010-10-01 |
| Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen (NCT01165684) | Novo Nordisk A/S | 2010-10-01 |
| Therapeutic Stockings to Prevent Foot Ulcers (NCT01221194) | University of Texas Southwestern Medical Center | 2010-10-01 |
| Adjustable Gastric Banding and Its Effects on Postprandial Glucose Metabolism Independent of Weight Loss (NCT01094054) | Mayo Clinic | 2010-10-01 |
| Diet and Activity Promotion Among Older Working Adults (NCT01233063) | Berkeley Analytics, Inc. | 2010-10-01 |
| Observational Study of NovoPen Echo® on Safety and Treatment Satisfaction in Children and Adolescents With Type 1 Diabetes (NCT01180530) | Novo Nordisk A/S | 2010-10-01 |
| The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes (NCT01319331) | University of Colorado, Denver | 2010-10-01 |
| Bile Acid-induced GLP-secretion. A Study in Cholecystectomized Subjects (NCT01251510) | University Hospital, Gentofte, Copenhagen | 2010-10-01 |
| Safety and Efficacy of Single Administration of Oshadi Oral Insulin in Type I Diabetes Patients (NCT01120912) | Oshadi Drug Administration | 2010-10-01 |
| Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients (NCT01219959) | Vantive Health LLC | 2010-10-01 |
| Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin Analogues (NCT01585506) | Novo Nordisk A/S | 2010-09-20 |
| Modulation of Free Fatty Acids in Heart Failure Patients With Diabetes: "Effect on Left Ventricular Function" (NCT01192373) | University of Aarhus | 2010-09-01 |
| Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes (NCT01147276) | Lund University | 2010-09-01 |
| Adolescent Fitness Assessment Program (NCT01382121) | University of Western Ontario, Canada | 2010-09-01 |
| Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes (NCT01226966) | Novo Nordisk A/S | 2010-09-01 |
| Therapeutic Lifestyle Modifications to Reduce Burden of Chronic Disease (NCT01277614) | The University of The West Indies | 2010-09-01 |
| Prognostic Indicators as Provided by the EPIC ClearView (NCT01476995) | Epic Research & Diagnostics, Inc. | 2010-09-01 |
| Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy Subjects (NCT00772265) | Wockhardt | 2010-09-01 |
| Metabolic Phenotyping of Individuals Born Following Assisted Reproduction Techniques (NCT01230632) | University of Adelaide | 2010-09-01 |
| Comparison of SoloSTAR With a Syringe-administered Glargine Insulin in Diabetic Patients From the Hospital (NCT01203774) | University of Colorado, Denver | 2010-09-01 |
| Diabetes Prevention Translation: the Healthy Lifestyle Project (NCT01050205) | University of Pittsburgh | 2010-09-01 |
| The Effectiveness of Lubiprostone in Constipated Diabetics (NCT01170039) | Emory University | 2010-09-01 |
| Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia (NCT01768403) | AstraZeneca | 2010-09-01 |
| Optimizing Insulin Absorption and Insulin Injection Technique in Older Adults (NCT01213901) | University of British Columbia | 2010-09-01 |
| Nonvisual Foot Inspection for People With Visual Impairment (NCT01822717) | Case Western Reserve University | 2010-09-01 |
| Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications - 2 (NCT01052714) | VA Office of Research and Development | 2010-09-01 |
| Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (NCT01179048) | Novo Nordisk A/S | 2010-08-31 |